Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT05595447. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT04533581. IPD Sharing: NO. Countries: 1. Publications: 1.
Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00989664. IPD Sharing: YES. Countries: 0. Publications: 1.
CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00374179. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dietary Milled Seed Mix in Patients With Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT03260231. IPD Sharing: NO. Countries: 1. Publications: 3.
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00004179. IPD Sharing: Not stated. Countries: 18. Publications: 6.
VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00036946. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Prognostic Value Of Lymphocyte Count and Lymphocyte/ Monocyte Ratio in Patients With Hodgkin's Lymphoma
ClinicalTrials.gov study NCT04893538. IPD Sharing: YES. Countries: 1. Publications: 6.
Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients With Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT03580408. IPD Sharing: NO. Countries: 2. Publications: 0.
AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma
ClinicalTrials.gov study NCT03434769. IPD Sharing: Not stated. Countries: 1. Publications: 2.
GHSG-AFM13 An Open-label, Multicenter Phase II Trial With AFM13 in Patients With Relapsed or Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT02321592. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT03671018. IPD Sharing: YES. Countries: 5. Publications: 1.
Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma
ClinicalTrials.gov study NCT00981097. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL)
ClinicalTrials.gov study NCT04245839. IPD Sharing: YES. Countries: 10. Publications: 1.
Treatment With Nivolumab at the Fixed Dose 40 mg (Nivo40) in Patients With Relapsed/Refractory Hodgkins Lymphoma
ClinicalTrials.gov study NCT03343665. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00032019. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Safety and Tolerability of BAY1862864 Injection in Subjects With Relapsed or Refractory CD22-positive Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT02581878. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01328626. IPD Sharing: NO. Countries: 2. Publications: 4.
Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients
ClinicalTrials.gov study NCT01516580. IPD Sharing: Not stated. Countries: 10. Publications: 3.
Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00359892. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.